SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-134375
Filing Date
2021-11-04
Accepted
2021-11-04 16:10:35
Documents
4
Period of Report
2021-12-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2130904-4_def14a.htm DEF 14A 628268
2 GRAPHIC sg_jillmilne-bw.jpg GRAPHIC 7184
3 GRAPHIC tm2130904d1-px_01cardbw.jpg GRAPHIC 775841
4 GRAPHIC tm2130904d1-px_02cardbw.jpg GRAPHIC 1232962
  Complete submission text file 0001104659-21-134375.txt   3402554
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 211380024
SIC: 2834 Pharmaceutical Preparations